Applicant, as named in the Orange Book
Takeda Pharms Usa
Takeda Pharmaceutical Co Ltd · NYSE: TAK
Company and ticker: cliffwatch mapping, checked against SEC EDGAR · SEC filings
Next listed expiry: Duetact on 8 Jun 2028. 17 products with live protection, 20 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Duetact NDA 021925 · 2 strengths glimepiride; pioglitazone hydrochloride | 8 Jun 2028 patent |
| Motegrity NDA 210166 · 2 strengths prucalopride succinate | 10 Jul 2028 exclusivity |
| Actoplus Met NDA 021842 metformin hydrochloride; pioglitazone hydrochloride | 3 Feb 2029 patent |
| Kazano NDA 203414 · 2 strengths alogliptin benzoate; metformin hydrochloride | 24 May 2029 patent |
| Oseni NDA 022426 · 4 strengths alogliptin benzoate; pioglitazone hydrochloride | 4 Jun 2029 patent |
| Nesina NDA 022271 · 3 strengths alogliptin benzoate | 16 Jun 2029 patent |
| Mydayis NDA 022063 · 4 strengths amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate | 24 Aug 2029 patent |
| Ninlaro NDA 208462 · 3 strengths ixazomib citrate | 20 Nov 2029 patent |
| Fosrenol NDA 204734 · 2 strengths lanthanum carbonate | 1 Dec 2030 patent |
| Uloric NDA 021856 · 2 strengths febuxostat | 8 Sep 2031 patent, carve-out possible |
| Dexilant NDA 022287 · 2 strengths dexlansoprazole | 5 Mar 2032 patent, carve-out possible |
| Trintellix NDA 204447 · 3 strengths vortioxetine hydrobromide | 21 Sep 2032 patent |
| Iclusig NDA 203469 · 4 strengths ponatinib hydrochloride | 12 Dec 2033 patent |
| Fruzaqla NDA 217564 · 2 strengths fruquintinib | 7 Sep 2035 patent |
| Alunbrig NDA 208772 · 3 strengths brigatinib | 10 Nov 2035 patent |
| Eohilia NDA 213976 budesonide | 10 Jan 2039 patent |
| Livtencity NDA 215596 maribavir | 11 Oct 2043 patent |
Recent events
- Rozerem · Generic approved · ANDA 215485, AdaptisApproved 4 Jun 2026Detected 25 Oct 2026
- Motegrity · Generic approved · ANDA 219234, AlembicApproved 27 Jul 2026Detected 25 Oct 2026
- Motegrity · Generic approved · ANDA 219220, Ajanta Pharma LtdApproved 16 Jan 2026Detected 25 Oct 2026
- Motegrity · Generic approved · ANDA 219180, Micro LabsApproved 29 Jun 2026Detected 25 Oct 2026
- Velcade · Generic approved · ANDA 216528, ShuangchengApproved 17 Dec 2025Detected 25 Oct 2026
- Trintellix · Generic tentatively approved · ANDA 211130, Apotex IncTentative approval 29 Jan 2026Detected 25 Oct 2026
- Lialda · Generic approved · ANDA 217736, Sciegen PharmsApproved 13 Oct 2026Detected 25 Oct 2026
- Trintellix · Generic tentatively approved · ANDA 211101, Msn Laboratories Private LtdTentative approval 3 Nov 2025Detected 25 Oct 2026
- Dexilant · Generic approved · ANDA 219115, AlembicApproved 12 Nov 2025Detected 25 Oct 2026
- Motegrity · Generic approved · ANDA 219071, Teva Pharms IncApproved 5 Feb 2026Detected 25 Oct 2026
- Livtencity · Exclusivity expires within 90 days NCEExclusivity expires 23 Nov 2026Detected 24 Oct 2026
Products without listed protection (20)
| Drug | Earliest generic entry |
|---|---|
| Actos NDA 021073 · 3 strengths pioglitazone hydrochloride | open now no listed protection |
| Adderall Xr 10 NDA 021303 amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate | open now no listed protection |
| Adderall Xr 15 NDA 021303 amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate | open now no listed protection |
| Adderall Xr 20 NDA 021303 amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate | open now no listed protection |
| Adderall Xr 25 NDA 021303 amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate | open now no listed protection |
| Adderall Xr 30 NDA 021303 amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate | open now no listed protection |
| Adderall Xr 5 NDA 021303 amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate | open now no listed protection |
| Carbatrol NDA 020712 · 3 strengths carbamazepine | open now no listed protection |
| Firazyr NDA 022150 icatibant acetate | open now no listed protection |
| Fosrenol NDA 021468 · 3 strengths lanthanum carbonate | open now no listed protection |
| Gattex Kit NDA 203441 teduglutide | open now no listed protection |
| Intuniv NDA 022037 · 4 strengths guanfacine hydrochloride | open now no listed protection |
| Lialda NDA 022000 mesalamine | open now no listed protection |
| Pentasa NDA 020049 · 2 strengths mesalamine | open now no listed protection |
| Prevacid NDA 020406 lansoprazole | open now no listed protection |
| Prevacid NDA 021428 · 2 strengths lansoprazole | open now no listed protection |
| Rozerem NDA 021782 ramelteon | open now no listed protection |
| Velcade NDA 021602 bortezomib | open now no listed protection |
| Vyvanse NDA 021977 · 7 strengths lisdexamfetamine dimesylate | open now no listed protection |
| Vyvanse NDA 208510 · 6 strengths lisdexamfetamine dimesylate | open now no listed protection |